Artificial Intelligence in Medical Technology Myths and Facts
Artificial intelligence (AI) and its subset, machine learning (ML), are expanding in multiple applications, including medical technology. Outlining the facts and dispelling myths will inform policymaking to avoid overlap with current regulations and preserve the broad capacity of innovation to help patients.
Related Reading
Event / China / Regulatory Affairs
China Regulatory Workshop
November 19, 2024 | 11:30 AM – 6:30 PM PT November 20, 2024 | 8:15 AM – 4:00 PM PT
Get the latest on new policy updates and guidance for the clinical evaluation of medical devices.
Event / Regulatory Affairs
Medical Device Submissions Workshops – 510(k) and De Novo
510(k) and De Novo Submissions Workshop: February 3-4, 2025
IDE Submissions Workshop: February 5, 2025
PMA Submissions Workshop: February 6-7, 2025
Our in-depth device submissions workshops will provide real-world case studies, tips and best practices directly from FDA and industry experts.
News / Regulatory Affairs
Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
July 31, 2024
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Shield™ blood test for colorectal cancer (CRC) screening in adults age 45 and older who are at average risk for the disease.
Event / Digital Health / Regulatory Affairs
AdvaMed Cybersecurity Summit
November 13, 2024
8:15 AM – 6:00 PM
Join us in Washington, D.C. for our Cybersecurity Summit that will address the future of medical device cybersecurity and changes in the industry landscape related to FDA requirements.
Resource / Regulatory Affairs
MedTech Reimbursement Playbook
July 17, 2024
Learn the basic principles of how medical technologies are covered and paid by insurers and the challenges medtech companies face.
Resource / Regulatory Affairs
Successful Market Access of SaMD & MDSW: Decoding the Confusion in MedTech Software Development
April 12, 2024
Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the medtech industry are playing a major role in improving patients’ lives through innovative care, reduced healthcare costs, and improved patient outcomes.
Resource / Regulatory Affairs
PFAS in Medtech
March 8, 2024
News / Ethylene Oxide / Regulatory Affairs
AdvaMed Anticipates EtO Sterilization Rule, Voices Concern About Impact on Patient Care
February 27, 2024
By Friday, March 1, the Environmental Protection Agency is expected to finalize its regulation for the ethylene oxide (EtO) sterilization of 20 billion, or half, of all medical devices in the United States each year. AdvaMed President and CEO Scott Whitaker released the following statement: